𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Severe hyperlipidemia in a child with acute lymphoblastic leukemia treated with L-asparaginase and prednisone

✍ Scribed by Fani Athanassiadou; Maria Kourti; Theodotis Papageorgiou; Maria Stamou; Areti Makedou; Amalia Boufidou

Book ID
108970918
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
85 KB
Volume
46
Category
Article
ISSN
1328-8067

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Remission induction with L-asparaginase,
Remission induction with L-asparaginase, vincristine, and prednisone in children with acute nonl ymphoblastic leukemia
✍ Land, Vita J. ;Sutow, Wataru W. ;Dyment, Paul G. ;Falletta, John M. ;Morgan, Sam πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 522 KB

## Abstract Forty‐five children with acute nonlymphoblastic leukemia in relapse received a total of 56 courses of L‐asparaginase combined with vincristine and prednisone. The complete remission rate of 40% (12 of 30 trials) in patients resistant to vincristine and prednisone was almost identical to

A prospective cohort study determining t
A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase : Results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study
✍ Lesley G. Mitchell;; the PARKAA Group πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 221 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Thrombotic events (TEs) are serious secondary complications in children with acute lymphoblastic leukemia (ALL) who receive L‐asparaginase (ASP) therapy; however, the prevalence of TEs has not been established. The primary objective of the Prophylactic Antithrombin Replac